If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJaywing Regulatory News (JWNG)

Share Price Information for Jaywing (JWNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.15
Bid: 3.10
Ask: 3.20
Change: 0.00 (0.00%)
Spread: 0.10 (3.226%)
Open: 3.15
High: 3.15
Low: 3.15
Prev. Close: 3.15
JWNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8

7 Mar 2024 15:00

RNS Number : 8966F
Jaywing PLC
07 March 2024
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Jaywing plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Jaywing plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

 The latest practicable date prior to the disclosure

6 March 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

 If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary Shares of £0.05

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

 

Nil

 

(2) Cash-settled derivatives:

 

Nil

 

Nil

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

 

Nil

 

 

TOTAL:

Nil

 

Nil

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

3(a) Interests held by the directors of Jaywing Plc and their close relatives and related trusts (excluding options and awards which are set out in 3(b) below):

 

Director

Position

Number of ordinary shares

Percentage of issued share capital1

Andrew Fryatt

Chief Executive

120,993

0.12%

Ian Robinson

Non-Executive Director

470,267

0.50%

Philip Hanson

Non-Executive Director

109,462

0.11%

1 Based on total voting rights in the Company is 93,332,595.

 

3(b) Options and awards held by certain directors of Jaywing Plc in ordinary shares issued under the LTIP / CSOP:

 

 

 

 

 

Date of Grant

 

 

 

 

Name of option holder

Number of ordinary shares under outstanding options

 

 

 

 

Vesting Date

 

 

Expiry Date

 

 

 

Exercise Price (p)

13 April 2023,

Andrew Fryatt (CSOP)

1,200,000

13 April 2026

13 April 2033

5p

13 April 2023,

Andrew Fryatt (LTIP)

576,000

13 April 2025

13 April 2033

5p

13 April 2023,

Andrew Fryatt (LTIP)

576,000

13 April 2027

13 April 2033

5p

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

6 March 2024

 

Contact name:

Christoper Hughes CFO

Telephone number:

44 (0)333 370 6500

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEGZGGFRVDGDZM
Date   Source Headline
10th Dec 202011:30 amRNSDirector/PDMR Shareholding
10th Dec 20207:00 amRNSHalf-year Report
26th Nov 20207:00 amRNSFinal Results
21st Oct 20207:00 amRNSExercise and completion of put option
29th Sep 20201:37 pmRNSResult of AGM
4th Sep 202010:05 amRNSNotice of AGM
26th Aug 20207:00 amRNSAppointment of CFO & Trading Update
29th Jul 20208:58 amRNSHolding(s) in Company
21st Apr 20207:00 amRNSDirectorate Change
26th Mar 20207:00 amRNSDirectorate Change
24th Mar 20207:00 amRNSDirectorate Change
18th Mar 20205:25 pmRNSAIM Rule 17 Notification
27th Jan 20207:00 amRNSDirectorate Change
20th Dec 20197:00 amRNSHalf-year Report
8th Nov 20199:10 amRNSHolding(s) in Company
8th Oct 20193:20 pmRNSNotice of GM
2nd Oct 20192:06 pmRNSPublication of Notice of AGM
2nd Oct 20197:00 amRNSFurther re. trading update & related party
30th Sep 20193:44 pmRNSResult of AGM
30th Sep 20197:00 amRNSAnnual Financial Report
26th Sep 20192:06 pmRNSSecond Price Monitoring Extn
26th Sep 20192:00 pmRNSPrice Monitoring Extension
13th Sep 201911:05 amRNSSecond Price Monitoring Extn
13th Sep 201911:00 amRNSPrice Monitoring Extension
12th Sep 20194:40 pmRNSSecond Price Monitoring Extn
12th Sep 20194:35 pmRNSPrice Monitoring Extension
11th Sep 20192:05 pmRNSSecond Price Monitoring Extn
11th Sep 20192:00 pmRNSPrice Monitoring Extension
30th Aug 20197:00 amRNSFurther re. trading update and results
6th Aug 20191:30 pmRNSAIM Rule 17 Notification
18th Jul 20195:07 pmRNSHolding(s) in Company
10th Jul 201911:37 amRNSTrading Statement
13th May 20197:00 amRNSAwards
2nd May 20197:00 amRNSTrading Statement
19th Feb 201911:32 amRNSHolding(s) in Company
10th Jan 20197:00 amRNSCompletion of Disposal
20th Nov 20187:01 amRNSHalf-year Report
20th Nov 20187:00 amRNSDisposal
29th Oct 20184:10 pmRNSHolding(s) in Company
11th Sep 20181:46 pmRNSResult of AGM and Trading Update
29th Aug 20187:00 amRNSClient Wins
16th Aug 20187:00 amRNSAnnual Financial Report
10th Jul 20189:41 amRNSFinal Results - Replacement
10th Jul 20187:00 amRNSFinal Results
25th Apr 20187:00 amRNSTrading Statement and Full Year Results Date
28th Mar 20184:03 pmRNSHolding(s) in Company
16th Mar 201810:28 amRNSHolding(s) in Company
15th Mar 20188:18 amRNSDirector/PDMR Shareholding
14th Mar 201812:06 pmRNSResult of General Meeting
27th Feb 20183:24 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.